193 related articles for article (PubMed ID: 33634940)
1. Ebp1 p48 promotes oncogenic properties in hepatocellular carcinoma through p38 MAPK/HIF1α activation and p53 downregulation.
Bao Y; Suvesh M; Li X; Bai X; Li H; Li X; Xu D; Liu L
Mol Carcinog; 2021 Apr; 60(4):252-264. PubMed ID: 33634940
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors.
Kim CK; Nguyen TL; Joo KM; Nam DH; Park J; Lee KH; Cho SW; Ahn JY
Cancer Res; 2010 Dec; 70(23):9730-41. PubMed ID: 21098709
[TBL] [Abstract][Full Text] [Related]
3. The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Hu B; Xiong Y; Ni R; Wei L; Jiang D; Wang G; Wu D; Xu T; Zhao F; Zhu M; Wan C
Mol Cell Biochem; 2014 Nov; 396(1-2):175-85. PubMed ID: 25081333
[TBL] [Abstract][Full Text] [Related]
4. Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis.
Nguyen DQ; Hoang DH; Nguyen TTV; Ho HD; Huynh V; Shin JH; Ly QT; Thi Nguyen DD; Ghoda L; Marcucci G; Nguyen LXT
J Cell Physiol; 2019 Aug; 234(10):17612-17621. PubMed ID: 30793766
[TBL] [Abstract][Full Text] [Related]
5. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
Lu WJ; Chua MS; So SK
Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
[TBL] [Abstract][Full Text] [Related]
6. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.
Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB
Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163
[TBL] [Abstract][Full Text] [Related]
7. EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells.
Pisapia L; Barba P; Cortese A; Cicatiello V; Morelli F; Del Pozzo G
Int J Oncol; 2015 Aug; 47(2):481-9. PubMed ID: 26081906
[TBL] [Abstract][Full Text] [Related]
8. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.
Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q
Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879
[TBL] [Abstract][Full Text] [Related]
9. Opposing roles of the two isoforms of ErbB3 binding protein 1 in human cancer cells.
Ko HR; Chang YS; Park WS; Ahn JY
Int J Cancer; 2016 Sep; 139(6):1202-8. PubMed ID: 27130196
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
11. S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
Wu R; Duan L; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
Int J Oncol; 2013 Mar; 42(3):1001-10. PubMed ID: 23354417
[TBL] [Abstract][Full Text] [Related]
12. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
[TBL] [Abstract][Full Text] [Related]
13. Ebp1 association with nucleophosmin/B23 is essential for regulating cell proliferation and suppressing apoptosis.
Okada M; Jang SW; Ye K
J Biol Chem; 2007 Dec; 282(50):36744-54. PubMed ID: 17951246
[TBL] [Abstract][Full Text] [Related]
14. p48 Ebp1 acts as a downstream mediator of Trk signaling in neurons, contributing neuronal differentiation.
Kwon IS; Ahn JY
Neurochem Int; 2011 Feb; 58(2):215-23. PubMed ID: 21145366
[TBL] [Abstract][Full Text] [Related]
15. BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway.
Feng PC; Ke XF; Kuang HL; Pan LL; Ye Q; Wu JB
Stem Cell Res Ther; 2019 Aug; 10(1):237. PubMed ID: 31387619
[TBL] [Abstract][Full Text] [Related]
16. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
[TBL] [Abstract][Full Text] [Related]
17. Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.
Chen SL; Liu LL; Wang CH; Lu SX; Yang X; He YF; Zhang CZ; Yun JP
Mol Oncol; 2020 Feb; 14(2):373-386. PubMed ID: 31670863
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the N-terminal domain of p48 Ebp1 by CDK2 is required for tumorigenic function of p48.
Ko HR; Kim CK; Ahn JY
Mol Carcinog; 2015 Nov; 54(11):1283-91. PubMed ID: 25154617
[TBL] [Abstract][Full Text] [Related]
19. The centrosomal protein Tax1 binding protein 2 is a novel tumor suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2.
Lai WL; Hung WY; Wong LL; Zhou Y; Leong VY; Lee JM; Ng IO; Jin DY; Ching YP
Hepatology; 2012 Nov; 56(5):1770-81. PubMed ID: 22610972
[TBL] [Abstract][Full Text] [Related]
20. Ebp1 isoforms distinctively regulate cell survival and differentiation.
Liu Z; Ahn JY; Liu X; Ye K
Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10917-22. PubMed ID: 16832058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
